全文获取类型
收费全文 | 587篇 |
免费 | 35篇 |
国内免费 | 7篇 |
专业分类
耳鼻咽喉 | 1篇 |
儿科学 | 39篇 |
妇产科学 | 2篇 |
基础医学 | 49篇 |
口腔科学 | 18篇 |
临床医学 | 41篇 |
内科学 | 137篇 |
皮肤病学 | 12篇 |
神经病学 | 14篇 |
特种医学 | 82篇 |
外科学 | 84篇 |
综合类 | 62篇 |
预防医学 | 30篇 |
眼科学 | 8篇 |
药学 | 29篇 |
肿瘤学 | 21篇 |
出版年
2024年 | 1篇 |
2023年 | 2篇 |
2022年 | 4篇 |
2021年 | 8篇 |
2020年 | 6篇 |
2019年 | 3篇 |
2018年 | 11篇 |
2017年 | 5篇 |
2016年 | 10篇 |
2015年 | 16篇 |
2014年 | 11篇 |
2013年 | 19篇 |
2012年 | 9篇 |
2011年 | 13篇 |
2010年 | 24篇 |
2009年 | 37篇 |
2008年 | 12篇 |
2007年 | 24篇 |
2006年 | 34篇 |
2005年 | 18篇 |
2004年 | 16篇 |
2003年 | 9篇 |
2002年 | 9篇 |
2001年 | 13篇 |
2000年 | 8篇 |
1999年 | 15篇 |
1998年 | 42篇 |
1997年 | 31篇 |
1996年 | 41篇 |
1995年 | 17篇 |
1994年 | 18篇 |
1993年 | 22篇 |
1992年 | 6篇 |
1991年 | 8篇 |
1990年 | 3篇 |
1989年 | 10篇 |
1988年 | 25篇 |
1987年 | 9篇 |
1986年 | 8篇 |
1985年 | 17篇 |
1984年 | 7篇 |
1983年 | 4篇 |
1982年 | 3篇 |
1981年 | 3篇 |
1980年 | 3篇 |
1977年 | 3篇 |
1976年 | 6篇 |
1975年 | 3篇 |
1879年 | 3篇 |
排序方式: 共有629条查询结果,搜索用时 31 毫秒
621.
Smith FO; Broudy VC; Zsebo KM; Lampkin BC; Buckley CV; Buckley JD; Opie T; Woods WG; Hammond GD; Bernstein ID 《Blood》1994,84(3):847-852
The prognostic significance of c-kit receptor expression on leukemic blast cells was determined in 122 children with acute myeloid leukemia (AML) entered onto Childrens Cancer Group protocol 213. Clinical and laboratory characteristics as well as outcome were analyzed according to the percentage of blast cells expressing c-kit receptors and the relative number of c-kit receptors per cell as determined by indirect immunofluorescence. c-kit receptor expression was strongly associated with the expression of the CD34 antigen. However, contrary to findings in adult patients with AML, c-kit receptor expression by childhood AML blast cells was not predictive of a poor response to therapy. 相似文献
622.
Genetic analysis is consistent with the hypothesis that NF1 limits myeloid cell growth through p21ras 总被引:6,自引:7,他引:6
Children with neurofibromatosis, type 1 (NF-1) are at increased risk of developing malignant myeloid disorders and their bone marrows frequently show loss of the normal allele of the NF1 tumor-suppressor gene. NF1 encodes a protein called neurofibromin, which accelerates guanosine triphosphate (GTP) hydrolysis on the p21ras (Ras) family of signaling proteins. We used a genetic approach to test the hypothesis that NF1 negatively regulates myeloid cell growth through its effect on Ras. This model predicts that, if RAS mutations and loss of NF1 function deregulate myeloid growth by the same biomechanical mechanism, then activating RAS mutations will be restricted to children with malignant myeloid disorders who do not have NF-1. We studied 71 children, including 28 with bone marrow monosomy 7 syndrome (Mo7), 35with juvenile chronic myelogenous leukemia (JCML), three with other forms of preleukemia, and five with acute myelogenous leukemia (AML), for activating mutations of KRAS and NRAS. The incidence of RAS mutations was 21% (12 of 55) in patients without NF-1 and 0% (zero of 16) in children with NF-1 (P = .04). Among the 55 patients who did not have NF-1, we found RAS mutations in four of 27 with Mo 7, in five of 24 with JCML, in two of 3 with AML, and in a patient with myeloproliferative syndrome (MPS). These data from primary human cancer cells provide strong genetic evidence that NF1 limits the growth of myeloid cells by regulating Ras. 相似文献
623.
Sanders JE; Pritchard S; Mahoney P; Amos D; Buckner CD; Witherspoon RP; Deeg HJ; Doney KC; Sullivan KM; Appelbaum FR 《Blood》1986,68(5):1129-1135
One hundred forty-two patients between the ages of 1 and 17 years who survived disease-free more than 1 year after marrow transplantation for hematologic malignancy had growth and development evaluations from one to 14 years posttransplant (median 4 years). Prior to transplant all children received multiagent chemotherapy and 55 also received central nervous system irradiation, but none had growth and development evaluations. Marrow transplant preparation included high-dose chemotherapy and total body irradiation (TBI) given as a single dose of 9.2 to 10.0 Gy (79 patients) or as fractionated doses of 2.0 to 2.25 Gy/d for six to seven days (63 patients). After transplant abnormal thyroid function was present in 39%. Stimulated 11-desoxycortisol levels were subnormal in 24% of patients evaluated. Growth hormone (GH) deficiency was present in 17 of 25 children who received previous cranial irradiation. Partial GH deficiency was present in 4 of 25 who received previous cranial irradiation and in 6 of 18 who had not received cranial irradiation. Height velocity was decreased in all patients. After transplant, height was significantly influenced by chronic graft-v-host disease and single-dose TBI. Sixty-eight percent had delayed development of secondary sexual characteristics. Gonadal failure occurred in nearly all who were postpubertal at transplant. While it is not possible to determine how many of these endocrine abnormalities occurred as a result of treatment administered prior to transplantation, these data do demonstrate that children who become long-term survivors after marrow transplantation for hematologic malignancy have endocrine abnormalities that adversely affect growth and development. 相似文献
624.
625.
Jo Kamen KM Fung Hector WH Tsang Raymond CK Chung 《Geriatrics & Gerontology International》2012,12(3):372-382
We aimed to fill the literature gap by identifying the clinical benefits of aromatherapy in older adults with dementia, and its efficacy in reducing behavioral and psychological symptoms of dementia (BPSD) based on available randomized controlled trials (RCT). A systematic review of 11 clinical trials shortlisted from electronic databases from 1995 to 2011 was carried out. The RCT showed that aromatherapy had positive effects on reduction of BPSD, improvement in cognitive functions, increasing quality of life, enhancing independence of activities of daily living and so on. However, adverse effects were noted in some studies. Limitations on methodology are discussed and suggestions on directions of further studies are made. It is recommended that aromatherapy shows the potential to be applied as a therapeutic and safe complementary and alternative therapy for the management of BPSD on more evidence collected from better designed RCT. Geriatr Gerontol Int 2012; 12: 372–382. 相似文献
626.
A one-step Du test, developed for use in automated microplate systems, uses anti-D with 0.6 percent dextran to potentiate the reaction. Because the washing and reagent-adding steps of the antiglobulin test are not required, the Du test can be performed in the same microplate as the ABO/Rh test. A set of reactions prepared with this technique was visually interpreted and also classified by an automated microplate ABO/Rh system. Visual interpretation of reactions resulted in a sensitivity and specificity close to those of the antiglobulin test, although the sensitivity of the test was reagent-dependent. When the automated microplate blood grouping system was used, the test was not as sensitive or as specific as the antiglobulin test, although it may be sufficient for many applications. 相似文献
627.
HLA profiles of 25 donor-specific transfusion (DST) kidney donor-recipient pairs were analyzed for HLA antigen compatibility. Serum samples collected during and after DST were tested for cytotoxic antibodies against T and B lymphocytes of the donors and 30 normal individuals. Eleven recipients did not produce cytotoxic antibodies to the antigens of their DST donors, and eight produced cold and/or warm, broadly reactive B-cell antibodies. Six patients (24%) produced HLA-A, B, C, and/or DR antibodies. Three of these individuals produced antibodies after two immunizations, while others required three immunizations. Three of the 11 antibody nonproducers (17%) had not received previous transfusions, as compared to three of the eight antibody producers (43%). Comparison of HLA profiles revealed 22 percent of the HLA-A, B, DR identities between the transfusion donor and recipient in antibody nonproducers as compared to 9 percent of the HLA-A, B, DR identities in antibody producers. The HLA-A2, B40, DR4 haplotype and HLA-DRW6 antigen were more common among antibody producers than among nonproducers, who had an excess of the HLA-B8, DR3 haplotype. These results are consistent with the hypothesis that there may be high- and low-responder HLA haplotypes that control immunologic responsiveness to histocompatibility antigens. 相似文献
628.
Antibodies against double-stranded DNA and development of polymyositis during treatment with interferon 总被引:6,自引:0,他引:6
Kalkner KM; Ronnblom L; Karlsson Parra AK; Bengtsson M; Olsson Y; Oberg K 《QJM : monthly journal of the Association of Physicians》1998,91(6):393-399
Alpha interferons have become effective palliative treatments for patients
with neuroendocrine tumours such as carcinoids and endocrine pancreatic
tumours. However, several reports indicate an increased incidence of both
autoantibodies and autoimmune diseases in patients treated with
interferon-alpha (IFN-alpha). We studied the development of antibodies
against double-stranded DNA (dsDNA) and clinical signs of autoimmune
disease in 214 patients with malignant carcinoids or endocrine pancreatic
tumours consecutively admitted for treatment with IFN-alpha. Seventeen
patients (8%) developed antibodies against dsDNA, predominantly females (12
females and 5 males). One patient had clinical and laboratory signs of
polymyositis. Among the other 16 patients, three developed hypothyroidism
and in six patients the anti- dsDNA autoantibodies normalized despite
continuing therapy. Although a significant number of patients developed
autoantibodies against dsDNA, overt autoimmune disease related to these
antibodies is a rare event and many patients spontaneously normalize these
titres despite continuing IFN-alpha treatment.
相似文献
629.